<SEC-DOCUMENT>0000929638-25-003494.txt : 20250916
<SEC-HEADER>0000929638-25-003494.hdr.sgml : 20250916
<ACCEPTANCE-DATETIME>20250916163538
ACCESSION NUMBER:		0000929638-25-003494
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250916
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250916
DATE AS OF CHANGE:		20250916

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cytosorbents Corp
		CENTRAL INDEX KEY:			0001175151
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980373793
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36792
		FILM NUMBER:		251317737

	BUSINESS ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		973-329-8885

	MAIL ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MedaSorb Technologies CORP
		DATE OF NAME CHANGE:	20060807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILDER ENTERPRISES INC
		DATE OF NAME CHANGE:	20020611
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:ctso="http://cytosorbents.com/20250916" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Morgan Lewis
         Document created using Broadridge PROfile 25.8.1.5328
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_9357b2a849b54920af59f4f74a222c84" contextRef="c20250916to20250916" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_1b40a8701ff842fcaf920ff4545dbfdf" contextRef="c20250916to20250916">0001175151</ix:nonNumeric><ix:nonNumeric name="dei:NoTradingSymbolFlag" id="Fact_51f5d2112cc745298e2657f326ec0bc0" contextRef="c20250916to20250916">true</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ctso-20250916.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250916to20250916"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-16</xbrli:startDate><xbrli:endDate>2025-09-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><br/>
  </div>

  <div style="font-family: 'Times New Roman', Times, serif;">
    <div style="color: #000000;">
      <div>
        <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="padding-bottom: 6pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_3b99f124105949f1bd8de16f8a1cbab2" contextRef="c20250916to20250916">8-K</ix:nonNumeric></div>

      <div style="text-align: center; font-weight: bold; font-size: 12pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-size: 10pt;">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>

      <div style="font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_6a5ab22f8ae74784b757e5fd5186f711" contextRef="c20250916to20250916" format="ixt:date-monthname-day-year-en">September 16, 2025</ix:nonNumeric></div>

      <div style="font-size: 12pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_13395299e819479cb62dec05289d1613" contextRef="c20250916to20250916">Cytosorbents Corp</ix:nonNumeric><br/>
      </div>

      <div style="font-size: 10pt; text-align: center;">(Exact name of registrant as specified in its charter) </div>

      <div style="font-size: 10pt; padding-bottom: 12pt;"> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; border-spacing: 0;">


  <tr>

    <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid #000000; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_ccc38173e0484de0bc526e78fb22c2e7" contextRef="c20250916to20250916" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 5%; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left; ">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid #000000; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_48144e28a0524f339cde7bfa3ee15dc9" contextRef="c20250916to20250916">001-36792</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 5%; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left; ">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid #000000; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_5295b46c17c24b45a8ea8306b28e3dc3" contextRef="c20250916to20250916">98-0373793</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; ">(State or other jurisdiction <br/>
                of incorporation)</div>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; ">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; ">(Commission <br/>
                File Number)</div>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; ">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; ">(IRS Employer <br/>
                Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 8pt;"> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; border-spacing: 0;">


  <tr>

    <td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center; font-size: 10pt; font-weight: bold;">
              <div><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_f92896f77e4a455cbaf4fab56d686120" contextRef="c20250916to20250916">305 COLLEGE ROAD EAST</ix:nonNumeric></div>
              <div><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_79c8799615454f8b833b9404530db075" contextRef="c20250916to20250916">PRINCETON</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_8413ae302a1e482887fb029d39f12555" contextRef="c20250916to20250916" format="ixt-sec:stateprovnameen">New Jersey</ix:nonNumeric></div>
            </td>

    <td style="width: 6%; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left;">&#160;</div>
            </td>

    <td style="width: 47%; vertical-align: bottom; text-align: center; font-size: 10pt; border-bottom: 2px solid #000000; font-weight: bold">
              <div><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_16f98526d9594f729233fcb0fbfb5c0a" contextRef="c20250916to20250916">08540</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; ">(Address of principal executive offices)</div>
            </td>

    <td style="width: 6%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; ">&#160;</div>
            </td>

    <td style="width: 47.48%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; ">(Zip code)</div>
            </td>

  </tr>


</table>
      <div style="font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 10pt;">Registrant's telephone number, including area code (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_0a4dfcf101b845c083225204bd660125" contextRef="c20250916to20250916">973</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_5f777f3bcbdb4b55aee9d59be9ddcb9c" contextRef="c20250916to20250916">329-8885</ix:nonNumeric></div>

      <div style="font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 10pt;">Not Applicable</div>

      <div style="text-align: center; font-size: 10pt;">(Former Name or Former Address, if Changed Since Last Report)</div>

      <div style="font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 10pt;"><span style="text-decoration: underline;">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:</span></div>

      <div style="text-align: center; font-size: 10pt;"> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; border-spacing: 0;">


  <tr>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; "><span style="text-decoration: underline;">Title of each class</span></div>
            </td>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; "><span style="text-decoration: underline;">Trading Symbol(s)</span></div>
            </td>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; "><span style="text-decoration: underline;">Name of each exchange on which registered</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:Security12gTitle" id="Fact_09185b0850064cc99108b90109d7b9e8" contextRef="c20250916to20250916">Common Stock, $0.001 par value</ix:nonNumeric><br/>
            </td>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt; text-align: center;">&#160;<br/>
            </td>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_b77c70b1176a4fd7ac7a82d41da08b05" contextRef="c20250916to20250916">NASDAQ</ix:nonNumeric><br/>
            </td>

  </tr>


</table>
      <div style="margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;"><br/>
      </div>

      <div style="text-align: left; margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;"> Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions (see General Instruction A.2. below): </div>

      <div style="text-align: left; margin-bottom: 7.1pt; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_08fefc81b95a4b4292ef4e0d8b76c157" contextRef="c20250916to20250916" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities
        Act (17 CFR 230.425)</div>

      <div style="text-align: left; margin-bottom: 6.95pt; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_55e1dbc616c44b1e912637d2f7f98a3c" contextRef="c20250916to20250916" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act
        (17 CFR 240.14a-12)</div>

      <div style="text-align: left; margin-bottom: 6.95pt; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_9bf4520df3194f4fa8ad8f30f4c6d935" contextRef="c20250916to20250916" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under
        the Exchange Act (17 CFR 240.14d-2(b))</div>

      <div style="text-align: left; margin-bottom: 2.05pt; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_fc554c0012dd43d7a46dd74687826c91" contextRef="c20250916to20250916" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under
        the Exchange Act (17 CFR 240.13e-4(c))</div>

      <div style="margin-bottom: 2.05pt; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
        of 1934 (&#167;240.12b-2 of this chapter):</div>

      <div><br/>
      </div>

      <div style="text-align: left; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_6f7a8c14bd214496a4d08bbb6b113b20" contextRef="c20250916to20250916" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div><br/>
      </div>

      <div style="text-align: left; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
        provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="margin-top: 6pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/> </div>

    </div>

  </div>

  <div><br/>
  </div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 10.12%; vertical-align: top; white-space: nowrap;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 7.01</div>
        </td>

    <td style="width: 80.88%; vertical-align: middle;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Regulation FD Disclosure.</div>
        </td>

  </tr>


</table>
  <div><br/>
  </div>

  <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On September 16, 2025, CytoSorbents Corporation (the &#8220;Company&#8221;) issued a press release providing a regulatory update on DrugSorb<sup>TM</sup>-ATR.&#160; A
    copy of the press release is furnished herewith as Exhibit 99.1.*</div>

  <div><br/>
  </div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 10.12%; vertical-align: top; white-space: nowrap;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 8.01</div>
        </td>

    <td style="width: 80.88%; vertical-align: middle;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Other Events.</div>
        </td>

  </tr>


</table>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

  <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information set forth under &#8220;Item 7.01 Regulation FD Disclosure&#8221; of this Current Report on Form 8-K is incorporated into this Item 8.01 by reference.</div>

  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 10.12%; vertical-align: top; white-space: nowrap;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</div>
        </td>

    <td style="width: 80.88%; vertical-align: middle;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibits.</div>
        </td>

  </tr>


</table>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(d) Exhibits</div>

  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

  <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 10.12%; vertical-align: top; border-bottom: 1px solid black;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Exhibit<br/>
            No.</span></div>
        </td>

    <td style="width: 80.88%; vertical-align: top; border-bottom: 1px solid black;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div>
        </td>

  </tr>

  <tr>

    <td style="width: 10.12%; vertical-align: top;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">99.1</div>
        </td>

    <td style="width: 80.88%; vertical-align: top;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Press Release of the Company, dated September 16, 2025</div>
        </td>

  </tr>

  <tr>

    <td style="width: 10.12%; vertical-align: top;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">104</div>
        </td>

    <td style="width: 80.88%; vertical-align: top;">
          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Cover Page Interactive Data File (embedded with the Inline XBRL document)</div>
        </td>

  </tr>


</table>
  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

  <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">* The information in Item 7.01 of this Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)
    or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.</div>

  <div>
    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>

    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">SIGNATURES</span></div>

    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
      the undersigned hereunto duly authorized.</div>

    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 37.34%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">Dated: September 16, 2025</div>
          </td>

    <td style="width: 62.66%; vertical-align: top;" colspan="2">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">CYTOSORBENTS CORPORATION</div>
          </td>

  </tr>

  <tr>

    <td style="width: 37.34%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 13.62%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 49.04%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
          </td>

  </tr>

  <tr>

    <td style="width: 37.34%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 13.62%; vertical-align: top;">
            <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">By:</div>
          </td>

    <td style="width: 49.04%; vertical-align: top; border-bottom: #000000 1.00pt solid;">
            <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">/s/ Dr. Phillip P. Chan</div>
          </td>

  </tr>

  <tr>

    <td style="width: 37.34%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 13.62%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">Name:</div>
          </td>

    <td style="width: 49.04%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">Dr. Phillip P. Chan</div>
          </td>

  </tr>

  <tr>

    <td style="width: 37.34%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>
          </td>

    <td style="width: 13.62%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">Title:</div>
          </td>

    <td style="width: 49.04%; vertical-align: top;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman', serif; font-size: 10pt;">Chief Executive Officer</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; font-family: 'Times New Roman', serif; font-size: 10pt;">&#160;</div>

  </div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exhbit99-1.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Morgan Lewis
         Document created using Broadridge PROfile 25.8.1.5328
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div><br>
  </div>
  <div><br>
  </div>
  <div>
    <div style="text-align: center;"><img src="image00001.jpg"></div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 8pt; font-family: Calibri, sans-serif; font-size: 16pt; font-weight: bold;">CytoSorbents Provides DrugSorb-ATR Regulatory Update</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">PRINCETON, N.J., September 16, 2025 &#8212;&#160;<font style="font-family: Calibri, sans-serif; font-size: 12pt; color: #0563C1;"><u>CytoSorbents Corporation</u></font> (NASDAQ:
      CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on DrugSorb&#8482;-ATR.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">On August 20, 2025, the Company announced that it had received a U.S. Food and Drug Administration (FDA) appeal decision regarding the FDA&#8217;s previous denial letter of
      the Company&#8217;s De Novo application for DrugSorb-ATR.&#160; In the appeal decision, the FDA found no issues with device safety but upheld its prior De Novo denial decision citing the need for additional information to support the Company&#8217;s desired label
      indication for this FDA Breakthrough Device.&#160; Additionally, the FDA proactively proposed a potential expedited path forward for market authorization but noted the Company could always appeal to a final higher level within the FDA with the Director of
      the FDA&#8217;s Center for Devices and Radiologic Health (CDRH).</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">The Company recently completed a constructive meeting with the FDA to review the content of the appeal decision and to align on a path forward, with several key
      outcomes.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z16377ff518534cf78cb7deb25f7da7ac" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: Calibri, sans-serif; font-size: 12pt;">1)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 12pt;">The Company has decided to not file a final appeal with CDRH because of positive FDA upper management feedback for a reasonable path forward that would allow for a suitable and
              potentially expedited De Novo grant for the Company&#8217;s original desired label indication.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zc18a87574bc74b6eb7d16435c28efc26" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: Calibri, sans-serif; font-size: 12pt;">2)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 12pt;">Based on this updated feedback, the Company plans to file a new De Novo application with additional information that includes analyses of new real-world data to support its desired
              label indication.&#160; This information was not available at the time of the original De Novo submission a year ago and therefore was not part of the administrative record, nor technically eligible to be submitted and reviewed, for the appeal
              meeting and decision.&#160; The Company believes these new real-world data, drawn from a population consistent with the intended DrugSorb-ATR use population (patients on ticagrelor undergoing urgent coronary artery bypass graft [CABG] surgery),
              reiterate the device&#8217;s robust clinical performance in everyday medical practice.&#160; Combined with the previously submitted clinical data on DrugSorb-ATR, the Company believes it further strengthens the favorable benefit-to-risk profile on which
              De Novo devices are evaluated.</div>
          </td>
        </tr>

    </table>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z787b46ec16f4448185b26c535f1554b5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: Calibri, sans-serif; font-size: 12pt;">3)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 12pt;">Based on discussions with the FDA, it is the Company&#8217;s understanding that the review of the new submission will focus only on the remaining open items from the initial De Novo
              submission.&#160; Again, the FDA found no safety issues in its prior review.&#160; The Company expects the new application to be reviewed in an expedited fashion under the auspices of the Breakthrough Device Designation previously granted for the
              device, which provides for priority and interactive review.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z0d3175ec751d482694077d146d639bda" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; font-family: Calibri, sans-serif; font-size: 12pt;">4)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: Calibri, sans-serif; font-size: 12pt;">As part of the resubmission process, the Company plans to file a pre-submission meeting request with supporting documentation to the FDA next month.&#160; A formal meeting with the
              Agency is anticipated in Q4 2025 to confirm the requirements for the new De Novo submission.&#160; Notwithstanding expected opportunities to accelerate the timeline, a standard regulatory decision is expected in mid-2026 following a timely De Novo
              submission and a typical 150-day review process.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">Dr. Phillip Chan, Chief Executive Officer of CytoSorbents, stated, &#8220;We are encouraged by the continued constructive dialogue with the FDA to define a clear and
      expedited path forward.&#160; We plan to move as quickly as possible to have our pre-submission meeting with the FDA to finalize alignment and to file our new De Novo application, which is expected to heavily leverage our original filing.&#160; We continue to
      have confidence in the performance and clinical value of DrugSorb-ATR for this major unmet medical need and the importance of making this FDA Breakthrough Designated Device available to the American public.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">Additionally, the Company had previously disclosed that it had filed a Level 1 &#8220;Request For Reconsideration&#8221; with Health Canada.&#160; However, following interactive
      discussions with the Medical Devices Directorate Bureau Director and the Company&#8217;s Canadian regulatory counsel, it was recommended that any subsequent review of DrugSorb-ATR in Canada be delayed until better clarity was received from the U.S. FDA.&#160;
      As such, the Company has withdrawn the Request for Reconsideration and will provide a new Medical Device License application to Health Canada with improved visibility from the FDA.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">Dr. Chan continued, &#8220;We remain committed to working collaboratively with both the FDA and Health Canada to secure marketing authorization for DrugSorb-ATR.&#160; Meanwhile,
      we continue to be focused on driving growth in our core business with key, high impact clinical applications, improving product gross margins, controlling costs, and driving efficiencies to manage our core business to near breakeven as we exit 2025.&#8221;</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: Calibri, sans-serif; font-size: 12pt; font-weight: bold;">About CytoSorbents Corporation (NASDAQ: CTSO)</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;"><font style="font-family: 'Times New Roman', serif; font-size: 11pt; color: #0000FF;"><u>CytoSorbents Corporation</u></font><font style="font-family: Calibri, sans-serif; font-size: 11pt;">&#160;</font>is a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification.&#160;&#160;CytoSorbents&#8217;&#160;proprietary blood purification technologies are based on
      biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. &#160;Cartridges filled with these beads can be used with standard blood pumps already found in
      hospitals (e.g. dialysis, continuous renal replacement therapy or CRRT, extracorporeal membrane oxygenation or ECMO, and heart-lung machines), where blood is repeatedly recirculated outside the body, through our cartridges where toxic substances are
      removed, and then back into the body.&#160;&#160;CytoSorbents&#8217;&#160;technologies are used in a number of broad applications.&#160; Specifically, two important applications are 1) the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of
      severe bleeding, and 2) the removal of inflammatory agents and toxins in common critical illnesses that can lead to massive inflammation, organ failure, and patient death. &#160;The breadth of these critical illnesses includes, for example, sepsis, burn
      injury, trauma, lung injury, liver failure, cytokine release syndrome, and pancreatitis, as well as the removal of liver toxins that accumulate in acute liver dysfunction or failure, and the removal of myoglobin in severe rhabdomyolysis that can
      otherwise lead to renal failure.&#160; In these diseases, the risk of death can be extremely high, and there are few, if any, effective treatments.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">CytoSorbents&#8217;&#160;lead product,&#160;CytoSorb&#174;, is approved in the&#160;European Union&#160;and distributed in over 70 countries worldwide, with nearly 300,000 devices used cumulatively
      to date.&#160; CytoSorb was originally launched in the&#160;European Union&#160;under CE mark as the first extracorporeal cytokine adsorber.&#160; Additional CE mark extensions were granted for bilirubin and myoglobin removal in clinical conditions such as liver disease
      and trauma, respectively, and for&#160;ticagrelor&#160;and&#160;rivaroxaban&#160;removal in cardiothoracic surgery procedures.&#160; CytoSorb has also received&#160;FDA Emergency Use Authorization&#160;in&#160;the United States&#160;for use in adult critically ill COVID-19 patients with
      impending or confirmed respiratory failure to reduce inflammatory cytokines.&#160; CytoSorb is not yet approved or cleared in&#160;the&#160;United States.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">In the&#160;U.S.&#160;and&#160;Canada,&#160;CytoSorbents&#160;is developing the DrugSorb&#8482;-ATR antithrombotic removal system, an investigational device based on an equivalent polymer technology
      to CytoSorb, to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs.&#160; It has received two&#160;FDA Breakthrough Device Designations:&#160; one for the removal of&#160;ticagrelor&#160;and another for the removal of the&#160;direct
      oral anticoagulants (DOAC) apixaban and rivaroxaban&#160;in a cardiopulmonary bypass circuit during urgent cardiothoracic procedures.&#160; The company is actively pursuing regulatory approval of DrugSorb-ATR with the U.S. FDA and will pursue</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt;">regulatory approval with Health Canada with better visibility from the FDA.&#160; DrugSorb-ATR is not yet granted or approved in either the U.S. or Canada.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: Calibri, sans-serif; font-size: 12pt;">The Company has numerous marketed products and products under development based upon this unique blood purification technology protected by many
        issued&#160;U.S.&#160;and international patents and registered trademarks, and multiple patent applications pending, including ECOS-300CY&#174;, CytoSorb-XL&#8482;, HemoDefend-RBC&#8482;, HemoDefend-BGA&#8482;, VetResQ&#174;, K+ontrol&#8482;, DrugSorb&#8482;, ContrastSorb, and others.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: Calibri, sans-serif; font-size: 12pt;"><font style="font-family: Calibri, sans-serif; font-size: 12pt;">For more information, please visit the Company&#8217;s website at&#160;https://ir.cytosorbents.com/&#160;&#160;or follow us on&#160;Facebook&#160;and&#160;X.&#160;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: Calibri, sans-serif; font-size: 12pt; font-weight: bold;">Forward-Looking Statements</div>
    <div style="text-align: justify; margin-bottom: 8pt; color: #000000; font-family: Calibri, sans-serif; font-size: 12pt;">This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by
        the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, future targets and outlooks for our business, representations and contentions, and the
        outcome of our regulatory submissions, and are not historical facts and typically are identified by use of terms such as &#8220;may,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue&#8221; and similar
        words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements in this press release represent management&#8217;s current judgment and expectations, but our actual results, events and
        performance could differ materially from those in the forward-looking statements. Factors which could cause or contribute to such differences include, but are not limited to our ability to successfully obtain U.S. FDA and Health Canada marketing
        authorization or approval, the ability to grow sales and cut costs, the outcome of the restructuring of our direct sales team and strategy in&#160;Germany, our ability to appropriately finance the Company, and the risks discussed in our Annual Report on
        Form 10-K, filed with the&#160;SEC&#160;on&#160;March 31, 2025, as updated by the risks reported in our Quarterly Reports on Form 10-Q, and in the press releases and other communications to shareholders issued by us from time to time which attempt to advise
        interested parties of the risks and factors which may affect our business.&#160; We caution you not to place undue reliance upon any such forward-looking statements.&#160; We undertake no obligation to publicly update or revise any forward-looking
        statements, whether as a result of new information, future events, or otherwise, other than as required under the Federal securities laws.</div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <div style="text-align: left; font-family: Calibri, sans-serif; font-size: 12pt;"><font style="font-family: Calibri, sans-serif; font-size: 12pt; font-weight: bold;">U.S. Company Contact:</font><font style="font-family: Calibri, sans-serif; font-size: 12pt;"><br>
      </font>Peter J. Mariani, Chief Financial Officer</div>
    <div style="text-align: left; font-family: Calibri, sans-serif; font-size: 12pt;">305 College Road East</div>
    <div style="text-align: left; font-family: Calibri, sans-serif; font-size: 12pt;">Princeton, NJ 08540</div>
    <div style="text-align: left; color: #0000FF; font-family: Calibri, sans-serif; font-size: 12pt;"><u>pmariani@cytosorbents.com</u></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: Calibri, sans-serif; font-size: 12pt; font-weight: bold;">Investor Relations Contact:</div>
    <div style="text-align: left; font-family: Calibri,sans-serif; font-size: 12pt; font-weight: normal;">Aman Patel, CFA &amp; Adanna G. Alexander, PhD</div>
    <div style="text-align: left; font-family: Calibri,sans-serif; font-size: 12pt; font-weight: normal;">ICR Healthcare</div>
    <div style="text-align: left; font-family: Calibri, sans-serif; font-size: 12pt;">ir@cytosorbents.com</div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ctso-20250916.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.8.1.5328 Broadridge-->
<xs:schema targetNamespace="http://cytosorbents.com/20250916" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:ctso="http://cytosorbents.com/20250916" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20250916_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20250916_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://cytosorbents.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ctso-20250916_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.8.1.5328 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="Security12gTitle" xlink:title="Security12gTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12gTitle" xml:lang="en-US" id="dei_Security12gTitle">Title of 12(g) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12gTitle" xlink:to="dei_Security12gTitle" xlink:title="label: Security12gTitle to dei_Security12gTitle" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ctso-20250916_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.8.1.5328 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://cytosorbents.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="ctso-20250916.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://cytosorbents.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="Security12gTitle" xlink:title="Security12gTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12gTitle" xlink:title="presentation: CoverAbstract to Security12gTitle" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "K 9T# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZIHHHH **
M** "BCFB@ HH-)0 M%)10 M%%%( HI#13 6BC-)0 M%)12 6BCO24P%HI*6@
M HI*!23 6BBBF 4444 %%%&* "BBB@ HHH-*X!10**8!1110 4444 %%!HS0
M 44E+F@ HHHI %%%%, HHHH **** "BBB@ HHHH *0]:4TTT@ GGVK@?%GQ7
M\->&[E[:>XDN[I#AHK8!BI]#G J+XX^)+CPWX*E:P9DN[IQ CJ<% <Y(/K7R
M4[$EF=BS-DD]"3_]>N_"X155S2V,YSL?2</Q_P!"+D2Z;J(7_952?_0J[_PC
MXXT/Q9$3I%XKS*,O W#K]1_A7RWXC\ ZGH/A;3];NWA-M=8^13\R9Z?6N=T?
M4KG1]3MK^RE:*>!@V\'J,_X5T3P5.<7*F]A*;ZGW6#3JXN;X@Z)I^C:1>:M<
M" ZC )HP!D'@9_G3M'^)/AC5]0BLK#4!)<2G"+CJ:\SV4][:%W1V1-&<USWB
MCQ?HWA=H1K-V(&F^X,9S[UF:9\2_"^J:A!8V5^KW,[;$7'4]?Z4E2FU=+0=U
M<[,L!U8?G2!U/0C\Z^7?C5XMO6\=/_8.N7 L1;QX^S3D)NYSTK+^&?BS5/\
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M\/ZU>_9\/_%T]/\ ^N$__H%35;>&YAKXCB_$FBW'AS6[K2;UD:>UVJQ4Y!)
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MH/TS7/\ QW\0:=X@\3V\FD7*W$,46TNAX+>QJC\$=.EU#XB:<8T<QP9E9\]
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MT&#7T#X+\,6/A/1(M.TY3L!W.YZNW<FM[;1C%35Q$ZOQ HV 4M HK$H****
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MK(WH4Y)'T%=8#GL12$]<&DG81YAX6A34_B#_ &SH>F3Z=I20%)G>,PBX?G^
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3 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 16, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 16,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cytosorbents Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001175151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0373793<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">305 COLLEGE ROAD EAST<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">PRINCETON<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">329-8885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12gTitle', window );">Title of 12(g) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12gTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(g) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection g<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12gTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="a8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cytosorbents.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="a8k.htm">a8k.htm</File>
    <File>ctso-20250916.xsd</File>
    <File>ctso-20250916_lab.xml</File>
    <File>ctso-20250916_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "a8k.htm": {
   "nsprefix": "ctso",
   "nsuri": "http://cytosorbents.com/20250916",
   "dts": {
    "inline": {
     "local": [
      "a8k.htm"
     ]
    },
    "schema": {
     "local": [
      "ctso-20250916.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ctso-20250916_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctso-20250916_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://cytosorbents.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250916to20250916",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "a8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250916to20250916",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "a8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://cytosorbents.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000929638-25-003494-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000929638-25-003494-xbrl.zip
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M$P"M%I!Y&*T&Z/4TG/,4G?-K-$[F)'Z]C]2;?91R$08'2%&GX?_Q <+Z(CM
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MY7)+%-!/A%D('G*>*><"AK)8BG0I4^99@H!"!0[8V//?2.R$6!K5JIW>4"4
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M_RV'Q/P-Z;[56H@;CDJRFS]02P,$%     @ <80P6^W;RI%U"   ,%8  !4
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MU_[X/U!+ 0(4 Q0    ( '&$,%L*H"2 <!(  "IG   '              "
M 0    !A.&LN:'1M4$L! A0#%     @ <80P6R52IV1& P  10\  !$
M         ( !E1(  &-T<V\M,C R-3 Y,38N>'-D4$L! A0#%     @ <80P
M6^W;RI%U"   ,%8  !4              ( !"A8  &-T<V\M,C R-3 Y,39?
M;&%B+GAM;%!+ 0(4 Q0    ( '&$,%L>41C6W 4  /D^   5
M  "  ;(>  !C='-O+3(P,C4P.3$V7W!R92YX;6Q02P4&      0 ! #Z
&P20

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>a8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ctso-20250916.xsd" xlink:type="simple"/>
    <context id="c20250916to20250916">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
        </entity>
        <period>
            <startDate>2025-09-16</startDate>
            <endDate>2025-09-16</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250916to20250916"
      id="Fact_9357b2a849b54920af59f4f74a222c84">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20250916to20250916"
      id="Fact_1b40a8701ff842fcaf920ff4545dbfdf">0001175151</dei:EntityCentralIndexKey>
    <dei:NoTradingSymbolFlag
      contextRef="c20250916to20250916"
      id="Fact_51f5d2112cc745298e2657f326ec0bc0">true</dei:NoTradingSymbolFlag>
    <dei:DocumentType
      contextRef="c20250916to20250916"
      id="Fact_3b99f124105949f1bd8de16f8a1cbab2">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250916to20250916"
      id="Fact_6a5ab22f8ae74784b757e5fd5186f711">2025-09-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250916to20250916"
      id="Fact_13395299e819479cb62dec05289d1613">Cytosorbents Corp</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250916to20250916"
      id="Fact_ccc38173e0484de0bc526e78fb22c2e7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250916to20250916"
      id="Fact_48144e28a0524f339cde7bfa3ee15dc9">001-36792</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250916to20250916"
      id="Fact_5295b46c17c24b45a8ea8306b28e3dc3">98-0373793</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250916to20250916"
      id="Fact_f92896f77e4a455cbaf4fab56d686120">305 COLLEGE ROAD EAST</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20250916to20250916"
      id="Fact_79c8799615454f8b833b9404530db075">PRINCETON</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250916to20250916"
      id="Fact_8413ae302a1e482887fb029d39f12555">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250916to20250916"
      id="Fact_16f98526d9594f729233fcb0fbfb5c0a">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250916to20250916"
      id="Fact_0a4dfcf101b845c083225204bd660125">973</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250916to20250916"
      id="Fact_5f777f3bcbdb4b55aee9d59be9ddcb9c">329-8885</dei:LocalPhoneNumber>
    <dei:Security12gTitle
      contextRef="c20250916to20250916"
      id="Fact_09185b0850064cc99108b90109d7b9e8">Common Stock, $0.001 par value</dei:Security12gTitle>
    <dei:SecurityExchangeName
      contextRef="c20250916to20250916"
      id="Fact_b77c70b1176a4fd7ac7a82d41da08b05">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications
      contextRef="c20250916to20250916"
      id="Fact_08fefc81b95a4b4292ef4e0d8b76c157">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250916to20250916"
      id="Fact_55e1dbc616c44b1e912637d2f7f98a3c">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250916to20250916"
      id="Fact_9bf4520df3194f4fa8ad8f30f4c6d935">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250916to20250916"
      id="Fact_fc554c0012dd43d7a46dd74687826c91">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250916to20250916"
      id="Fact_6f7a8c14bd214496a4d08bbb6b113b20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
